Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kymera Therapeutics Inc. June 25, 202594.7%
-
Spyre Therapeutics Inc. May 13, 202479.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Spyre Therapeutics Inc. | Option exercise | +5,000 | $10.39 | $51,950 |
| Aug 7, 2026 | Spyre Therapeutics Inc. | Open-market sale | −5,000 | $104.47 | $522,350 |
| Aug 7, 2026 | Spyre Therapeutics Inc. | Open-market sale | −8,000 | $104.38 | $835,040 |
| Aug 7, 2026 | Spyre Therapeutics Inc. | Open-market sale | −10,000 | $104.68 | $1,046,800 |
| Dec 8, 2025 | Kymera Therapeutics Inc. | Option exercise | +5,000 | $14.18 | $70,900 |
| Dec 8, 2025 | Kymera Therapeutics Inc. | Open-market sale | −2,748 | $89.32 | $245,451 |
| Dec 8, 2025 | Kymera Therapeutics Inc. | Open-market sale | −2,252 | $90.30 | $203,356 |
| Oct 13, 2025 | Kymera Therapeutics Inc. | Option exercise | +5,000 | $10.34 | $51,700 |
| Oct 13, 2025 | Kymera Therapeutics Inc. | Open-market sale | −5,000 | $59.19 | $295,950 |
| Jun 3, 2025 | Kymera Therapeutics Inc. | Option exercise | +6,349 | $10.34 | $65,649 |
| Jun 3, 2025 | Kymera Therapeutics Inc. | Open-market sale | −6,349 | $49.00 | $311,101 |
| Nov 6, 2024 | Spyre Therapeutics Inc. | Open-market sale | −6,700 | $36.76 | $246,292 |
| Oct 25, 2024 | Spyre Therapeutics Inc. | Open-market sale | −300 | $36.43 | $10,929 |
| Aug 26, 2024 | Kymera Therapeutics Inc. | Option exercise | +5,000 | $10.34 | $51,700 |
| Aug 26, 2024 | Kymera Therapeutics Inc. | Open-market sale | −5,000 | $49.10 | $245,500 |
Questions about Jeffrey W. Albers
What boards is Jeffrey W. Albers on?
Jeffrey W. Albers sits on the boards of Kymera Therapeutics Inc. and Spyre Therapeutics Inc.
How long has Jeffrey W. Albers served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.